A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD

NCT06941350 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Graft-versus-Host Disease

Interventions

BIOLOGICAL: NCR102 injection

Sponsor

Nuwacell Biotechnologies Co., Ltd.